Service by

Home Journal Issues Guide for Authors Editorial Board About Aims & Scope Editorial Contact


Original Research Open Access


A six-month follow-up study to evaluate changes of pulmonary function test in Category I pulmonary tuberculosis treatment completed patient

Prashant J Patil, Sarika P Patil.

Abstract
Background: Tuberculosis (TB) is being a preventable and curable disease that it accounts the world-wide problem. India is one of the TB burden countries. Clinical manifestation of pulmonary TB leads pulmonary dysfunction with functional changes in the lung tissue. Treated patients are free from mycobacterium and considered cured, but the restoration of lungs function in these patients is also needed.

Aims and Objectives: This study plans to evaluate and compare the pulmonary function test (PFT) parameters immediately, 3 months and 6 months after the completion of TB treatment and assess its severity.

Materials and Methods: By convenient sampling, 118 voluntarily participated pulmonary TB-treated patients completing Category I regimen. PFT during three intervals after the completion of full course of antitubercular drugs was evaluated. Spirometry was done in sitting position according to the American Thoracic Society (ATS) recommendation and interpretation of the results was done.

Results: Male-to-female proportion of the pulmonary TB patients was 56.8% versus 43.2%, respectively, within 22-65 years. Maximum patients, that is, 39% were within 31-40-year-age group. Immediate after completion of the treatment, 7.6% had symptoms of exertion dyspnea which were not on follow-up visits. The percent predictive values of the PFT were marginally above the impairment values. There was statistically significant difference mean forced vital capacity (FVC) (P < 0.001), forced expiratory volume at one second/FVC ratio percentage (P < 0.01), peak expiratory flow rate (P < 0.05), and maximal voluntary ventilation (P < 0.01) at the three intervals. Pulmonary function results were normal in 89.8% of patients immediately after the completion of TB treatment, in 91.5% at 3 months and 88.1% at 6 months. Impaired pulmonary function values were in 10.2% of patients at immediate, 8.5% at 3 months, and 11.9% patients at 6 months after completion of TB treatment. The 6-month PFT findings in 6.8% had obstructive changes, 3.4% had restrictive, and 1.7% with mixed PFT changes.

Conclusion: There is the presence of pulmonary functional limitations in Category I TB-treated patients. Values for PFT were still lower in few patients even after completion of 6 months of treatment for Category I pulmonary TB.

Key words: Pulmonary Tuberculosis; Pulmonary Function Test; Category I Regimen; Spirometry; American Thoracic Society; Forced Expiratory Volume at One Second; Peak Expiratory Flow Rate; Forced Vital Capacity; Maximal Voluntary


 
ARTICLE TOOLS
Abstract
PDF Fulltext
Print this article Print this Article
How to cite this articleHow to cite this article
Export to
Export to
Related Records
 Articles by Prashant J Patil
Articles by Sarika P Patil
on Google
on Google Scholar
Article Statistics
 Viewed: 206
Downloaded: 54
Cited: 0


How to Cite this Article
Pubmed Style

Patil PJ, Patil SP. A six-month follow-up study to evaluate changes of pulmonary function test in Category I pulmonary tuberculosis treatment completed patient. Natl J Physiol Pharm Pharmacol. 2018; 8(1): 31-36. doi:10.5455/njppp.2018.8.0724121072017


Web Style

Patil PJ, Patil SP. A six-month follow-up study to evaluate changes of pulmonary function test in Category I pulmonary tuberculosis treatment completed patient. http://www.njppp.com/?mno=271264 [Access: January 23, 2018]. doi:10.5455/njppp.2018.8.0724121072017


AMA (American Medical Association) Style

Patil PJ, Patil SP. A six-month follow-up study to evaluate changes of pulmonary function test in Category I pulmonary tuberculosis treatment completed patient. Natl J Physiol Pharm Pharmacol. 2018; 8(1): 31-36. doi:10.5455/njppp.2018.8.0724121072017



Vancouver/ICMJE Style

Patil PJ, Patil SP. A six-month follow-up study to evaluate changes of pulmonary function test in Category I pulmonary tuberculosis treatment completed patient. Natl J Physiol Pharm Pharmacol. (2018), [cited January 23, 2018]; 8(1): 31-36. doi:10.5455/njppp.2018.8.0724121072017



Harvard Style

Patil, P. J. & Patil, S. P. (2018) A six-month follow-up study to evaluate changes of pulmonary function test in Category I pulmonary tuberculosis treatment completed patient. Natl J Physiol Pharm Pharmacol, 8 (1), 31-36. doi:10.5455/njppp.2018.8.0724121072017



Turabian Style

Patil, Prashant J, and Sarika P Patil. 2018. A six-month follow-up study to evaluate changes of pulmonary function test in Category I pulmonary tuberculosis treatment completed patient. National Journal of Physiology, Pharmacy and Pharmacology, 8 (1), 31-36. doi:10.5455/njppp.2018.8.0724121072017



Chicago Style

Patil, Prashant J, and Sarika P Patil. "A six-month follow-up study to evaluate changes of pulmonary function test in Category I pulmonary tuberculosis treatment completed patient." National Journal of Physiology, Pharmacy and Pharmacology 8 (2018), 31-36. doi:10.5455/njppp.2018.8.0724121072017



MLA (The Modern Language Association) Style

Patil, Prashant J, and Sarika P Patil. "A six-month follow-up study to evaluate changes of pulmonary function test in Category I pulmonary tuberculosis treatment completed patient." National Journal of Physiology, Pharmacy and Pharmacology 8.1 (2018), 31-36. Print. doi:10.5455/njppp.2018.8.0724121072017



APA (American Psychological Association) Style

Patil, P. J. & Patil, S. P. (2018) A six-month follow-up study to evaluate changes of pulmonary function test in Category I pulmonary tuberculosis treatment completed patient. National Journal of Physiology, Pharmacy and Pharmacology, 8 (1), 31-36. doi:10.5455/njppp.2018.8.0724121072017



AUTHOR LOGIN

REVIEWER LOGIN

Indexed In

 

National Journal of Physiology, Pharmacy and Pharmacology is Indexed in -

EMBASE

Index Copernicus  (ICV 2016: 109)

Index Medicus for SEAR

CAB abstract/Global Health

CINAHL

Hinari

Google Scholar

ScopeMed

Ulrich’s International Periodical Directory

Indian Science Abstracts

Open J- Gate

Geneva Foundation for Medical Education and Research

NewJour

PSOAR

InformIndia

EBSCO Publishing Electronic Database

Genamics JournalSeek

ProQuest

Index Scholar

SafetyLit

Chemical Abstracts Service (CAS)

Gale's Health Reference Center

Gale Info Trac

Gale Academic Onefile

Ind Medica

Scirus

Scientific Publication Index

Scientific Resources Database

Recent Science Index

Scholarly Journals Index

Directory of Academic Resources

Elite Scientific Journals Archives

Current Index to Scholarly Journals

Digital Journals Database

Academic Papers Database

Contemporary Research Index

Ayush Web Portal

CiteFactor

 

 

 

 

 

 

Journal Membership

World Association of Medical Editors (WAME), Dallas, Texas, USA

 

Journal Listed in

ICMJE- International Committee of Medical Journal Editors

HIFA 2015 – Healthcare Information for All by 2015, Charlbury, Oxfordshire, UK 

 

 


The articles in this Journal are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-sa/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.